MAPS Public Benefit Corp. closed a $100 million Series A funding round and rebranded as Lykos Therapeutics, the company announced Thursday. The funding, which will support the company’s development of MDMA-assisted therapy for post-traumatic stress disorder, comes from a range of new investors, alongside the conversion of an undisclosed sum …

The new law states, “It is unlawful for an employer to discriminate against a person in the initial hiring for employment if the discrimination is based upon the person’s use of cannabis off the job and away from the workplace.” The post Washington: New State Law Takes Effect Barring Pre-Employment Marijuana Testing for Most Employees appeared first on NORML.